Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Attention centers on SELLASs Phase 3 REGAL topline results for GPS, with managements stated November timeline intensifying focus on the final analysis. Traders are split between optimistic expectations and short-squeeze speculation versus concerns about the binary outcome, delays, and recent share-price weakness.

Cerebras is drawing attention after quarterly results and an upbeat revenue outlook, with traders highlighting cloud growth and a reported Microsoft deal. Bulls emphasize the raised guidance and AI demand, while skeptics point to widening losses, heavy spending, and whether growth justifies the valuation.

Candels planned prostate-cancer BLA filing was pushed to mid-2027 amid FDA dialogue and assay-refinement work, prompting a sharp selloff and concern about a longer catalyst gap. Traders are split between viewing it as a manageable manufacturing/CMC delay with clinical data intact and questioning managements credibility and the risk of further delays or dilution.

Ciscos quarterly results beat expectations and the company raised its outlook, including its AI infrastructure ambitions. Traders are divided over the muted, volatile reaction: some see profit-taking despite strong results, while others question whether AI demand will translate into durable growth.

A disappointing third-quarter report, softer sequential ANKTIVA sales, and concerns about cash burn, possible dilution, and limited management guidance are driving the selloff discussion. Some traders view the reaction as excessive and point to the positive BCG-nave trial result and potential expansion, while others question commercial execution and the funding outlook.

Hot inflation data has lifted Treasury yields and Fed rate-hike expectations, while a stronger dollar has pressured gold and driven a sharp GLD selloff. Traders are split between buying the dip and expecting further declines, with some questioning golds safe-haven appeal amid the weakness.

Nu Holdings is drawing attention after its Q3 earnings report, with traders weighing strong revenue and profit growth and improving efficiency against concerns about rising delinquencies, credit quality, and whether the results met expectations. Reactions are split, with some viewing the selloff despite solid results as an overreaction and others seeing weaker credit metrics and muted stock performance as reasons for caution.

Applied Materials quarterly results topped expectations and its next-quarter outlook was stronger than consensus, but the shares barely responded and sold off. Traders are debating whether the good news was already priced in, with some questioning how strong the guidance looks after adjusting for an extra week in the quarter; others point to options volatility and broader weakness in chip stocks.

A sharp selloff followed Cardinals weak quarterly results, withdrawn full-year guidance and disclosure that its CFO plans to leave, with traders focused on worsening project margins and managements execution. The community is split between concerns about further deterioration and bankruptcy risk, and hopes that the stock is oversold and the authorized buyback could support a recovery; the authorization does not confirm that repurchases have begun.

Flowers Foods declining bread volumes, pressured earnings outlook, and credit-rating downgrades tied to weaker performance and leverage are fueling concern that the business may keep deteriorating. Traders are split between short sellers expecting further declines and bargain hunters who view the selloff and heavy short interest as potential support for a rebound or squeeze.